Otsuka Pharmaceutical Co., Ltd. et al v. MSN Laboratories Private Ltd. et al > Summary
Court Case Number 1:20-cv-01428
Filing Date Oct 23, 2020
Termination Date Oct 14, 2022
Court Delaware District Court
Status Judgment - Judgment on Consent
JudgesLeonard P. Stark
Plaintiff Attorneys
13Otsuka Pharmaceutical
Attorney Name: Steven J. Balick
Ashby & Geddes
Otsuka Pharmaceutical
Attorney Name: Andrew C. Mayo
Ashby & Geddes
Otsuka Pharmaceutical
Attorney Name: James B. Monroe
Finnegan, Henderson, Farabow, Garrett & Dunner
Otsuka Pharmaceutical
Attorney Name: Denise Main
Finnegan, Henderson, Farabow, Garrett & Dunner
Otsuka Pharmaceutical
Attorney Name: Erin McGeehan Sommers
Finnegan, Henderson, Farabow, Garrett & Dunner
Otsuka Pharmaceutical
Attorney Name: Collette Corser
Finnegan, Henderson, Farabow, Garrett & Dunner
Otsuka Pharmaceutical
Attorney Name: Tyler B. Latcham
Finnegan, Henderson, Farabow, Garrett & Dunner
H. Lundbeck A/S
Attorney Name: Steven J. Balick
Ashby & Geddes
H. Lundbeck A/S
Attorney Name: Collette Corser
Finnegan, Henderson, Farabow, Garrett & Dunner
H. Lundbeck A/S
Attorney Name: Tyler B. Latcham
Finnegan, Henderson, Farabow, Garrett & Dunner
H. Lundbeck A/S
Attorney Name: Denise Main
Finnegan, Henderson, Farabow, Garrett & Dunner
H. Lundbeck A/S
Attorney Name: Andrew C. Mayo
Ashby & Geddes
H. Lundbeck A/S
Attorney Name: Erin McGeehan Sommers
Finnegan, Henderson, Farabow, Garrett & Dunner
Defendant Attorneys
9MSN Laboratories
Attorney Name: April M. Ferraro
Abrams & Bayliss LLP
MSN Laboratories
Attorney Name: John M. Seaman
Abrams & Bayliss LLP
MSN Laboratories
Attorney Name: Neal Seth
Wiley Rein LLP
MSN Laboratories
Attorney Name: Teresa Summers
Wiley Rein LLP
MSN Pharmaceuticals Inc.
Attorney Name: April M. Ferraro
Abrams & Bayliss LLP
MSN Pharmaceuticals Inc.
Attorney Name: John M. Seaman
Abrams & Bayliss LLP
MSN Pharmaceuticals Inc.
Attorney Name: Neal Seth
Wiley Rein LLP
MSN Pharmaceuticals Inc.
Attorney Name: Teresa Summers
Wiley Rein LLP
MSN Pharmaceuticals Inc.
Attorney Name: April M. Kirby
MSN Pharmaceuticals Inc.
Cause
35:271 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| RE048059 | Piperazine-substituted benzothiophenes for treatment of mental disorders | Jun 23, 2020 |
| 07888362 | Piperazine-substituted benzothiophenes for treatment of mental disorders | Feb 15, 2011 |
